Belgium· BE-AMP-SAM435565-00

Desolina 30 0.15 mg - 0.03 mg

A desogestrel and ethinylestradiol product containing desogestrel, registered in Belgium by Ceres Pharma. The same ATC class is registered in 11 of our 19 countries.

ATC G03AA09

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about desogestrelAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Desogestrel and ethinylestradiol is registered in 11 of 19 countries.

Countries holding a registration under ATC G03AA09 (desogestrel and ethinylestradiol), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
7 of them publish a price we can compare per daily dose

Search desogestrel and ethinylestradiol products by name

Desogestrel and ethinylestradiol · ATC G03AA09

11 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Desogestrel
Manufacturer: Ceres Pharma
Country: Belgium (BE)
ATC code: G03AA09
ATC class: Desogestrel and ethinylestradiol
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 5

be_apb
3951068
be_apb
7725930
be_apb
3419504
be_apb
3951076
be_apb
3958873

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

494 interactions on record for desogestrel and ethinylestradiol.

Graded by severity as the source publishes them — 40 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check desogestrel and ethinylestradiol against other medicines How interaction checks work

Desogestrel and ethinylestradiol · interactions on record

494 records

40 severe
372 moderate
49 minor

Most severe, free to view

Tranexamic acidB02AA02severe
HeminB06AB01severe
BosentanC02KX01severe
GriseofulvinD01AA08severe

33 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Desogestrel and ethinylestradiol in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All desogestrel and ethinylestradiol products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

Austria · Cerazette, Cycle
Czechia · Azalia, Cerazette
Germany · Cerazette, Chalant
Denmark · Azalia, Ceranor
Estonia · Cerazette, Delamonie
Spain · Aiacet, Azalia
Finland · Azalia, Ceranor
France · Antigone, Cerazette
United Kingdom (Northern Ireland) · Aizea, Cerazette
Greece · Cerazette
Hungary · Azalia, Cerazette
Ireland · Azalia, Cerazette
Iceland · Cerazette, Desirett
Italy · Aimi, Azalia
Lithuania · Azalia, Desirett
Luxembourg · Cerazette, Desirett
Latvia · Azalia, Desirett
Malta · Azalia, Desogestrel Rowex
Netherlands · Cerazette, Delamonie
Norway · Azalia, Cerazette
Poland · Azalia, Cerazette
Portugal · Azalia, Cerazette
Romania · Azalia, Cerazette
Sweden · Azalia, Ceranor
Slovenia · Cerazette, Cerelle
Slovakia · Azalia, Desirett

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/fe0ef128-4629-4b01-9179-4f5b93f90a13
GET /v1/drugs/fe0ef128-4629-4b01-9179-4f5b93f90a13?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Desolina 30 0.15 mg - 0.03 mg",
  "name_fr": "Desolina 30 0.15 mg - 0.03 mg",
  "name_nl": "Desolina 30 0.15 mg - 0.03 mg",
  "amp_code": "SAM435565-00",
  "strengths": [
    "0.1500",
    "0.0300",
    "54.9700"
  ],
  "pack_count": 4,
  "substances": [
    "Desogestrel",
    "Ethinylestradiol",
    "Lactose Monohydrate",
    "Polysorbate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Desogestrel and Ethinylestradiol",
  "authorisation_numbers": [
    "BE435565"
  ]
}

API reference MCP server Plans

See everything about desogestrel and ethinylestradiol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console